drugset / Trial / NCT00079911

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

NCT00079911

Phase 4 Terminated 7 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical research study will be an international trial evaluating the safety and effectiveness of a marketed drug compared to placebo (like a sugar pill) for the suppression of repeated genital herpes infections in HIV-infected subjects with CD4+ count \<100 cells/mm3.

Timeline

Start
2004-03-12
Primary completion
2004-10-15
Completion
2004-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Valacyclovir Unknown 500 mg

Indications